100% found this document useful (1 vote)
714 views32 pages

Adverse Effects of Blood Transfusion: 6 Edition

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
100% found this document useful (1 vote)
714 views32 pages

Adverse Effects of Blood Transfusion: 6 Edition

Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 32

Modern Blood Banking & Transfusion Practices

6th Edition

Chapter 16

Adverse Effects of Blood Transfusion

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Introduction
 A transfusion reaction is defined as any
transfusion-related adverse event that occurs
during or after the transfusion of whole blood,
blood components, or human-derived plasma
products.
 Acute transfusion reactions
 Delayed transfusion reactions
 Immune versus non-immune reactions
 Infectious versus non-infectious reactions

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Risks
 Transfusion reactions have different
associated outcomes that can be the cause of
increased morbidity or even mortality.
 Some transfusion-associated adverse events
can be prevented, others cannot.
 The diagnosis and treatment of a transfusion
reaction is a multidisciplinary task.

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Recognition, Evaluation and


Resolution
 The initial step involves the patient, the
transfusionist, and the physician responsible
for the patient at the time of transfusion.
 The intermediate step and final steps involve
the Transfusion Service technical staff and
the Transfusion Service physician.

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Basic Immunohematology Testing


 The initial transfusion reaction work-up by
the technical staff consists of steps to rule out
a hemolytic transfusion reaction.
 Presence of hemolysis/hemolysis ruled out and
subsequent testing and evaluation

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Basic Immunohematology Testing


(cont’d)
 Secondary testing performed according to the
presenting signs/symptoms and evolution of
the transfusion reaction as requested by the
Transfusion Service physician
 Tasks of medical personnel in transfusion
reaction recognition, evaluation, and resolution

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Acute Transfusion Reactions


 A reaction in which signs and symptoms
present during or within 24 hours of a
transfusion
 Most can be grouped according to the
common etiology that gives similar
presenting signs and symptoms

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Acute Hemolytic Transfusion Reaction


(AHTR)
 Consists of acute hemolysis with
accompanying symptoms during/within 24
hours of transfusion
 Accompanying signs and symptoms of
immune mediated acute hemolytic
transfusion reaction

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Acute Hemolytic Transfusion Reaction


(AHTR) (cont’d)
 Reaction process
 IgM or IgG antibodies in the recipient recognize
corresponding donor red cell antigens.
 Immune complexes are formed.
 The complement cascade is activated.
 Vasoactive amines and inflammatory mediators are
released.
 The coagulation cascade is activated.

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Immune Mediated Acute Hemolytic


Transfusion Reaction
 The activated lytic arm (membrane attack
complex) of the complement cascade causes
hemoglobinemia and hemoglobinuria, the
hallmarks of intravascular hemolysis.

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Nonimmune Acute Hemolytic


Transfusion Reaction
 Most frequently presents as asymptomatic
hemoglobinuria; occasional renal
dysfunction; rarely death
 Pathophysiology independent of the
presence of antibodies
 Possible causes

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Immune Mediated Acute Hemolytic


Transfusion Reaction (Immune AHTR)
 When an immune AHTR is suspected, the
transfusion must be discontinued
immediately, a clerical verification performed,
and the patient’s physician notified.
 Required notification and documentation actions
 Required blood and urine samples
 Gather documents, samples, component bag(s)

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Immune Mediated Acute Hemolytic


Transfusion Reaction (Immune AHTR)
(cont’d)
 If the post-reaction blood sample appears
hemolyzed upon inspection, a second sample should
be requested to verify hemolysis.
 If the DAT performed in the post-reaction sample
shows a “new” or stronger positivity than the pre-
reaction sample DAT, further work-up is needed.
 Required samples/testing for time frames for the
indicators affected by intravascular hemolysis
Copyright © 2012 F.A. Davis Company
Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion-Associated Sepsis (TAS)


 Acute non-immune transfusion reaction with
fever, usually with greater than 2C increase in
body temperature and rigors that can be
accompanied by hypotension
 Occurs when a bacteria-contaminated blood
component is transfused
 Mortality risks

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion-Associated Sepsis (TAS)


(cont’d)
 Commonly implicated bacterial organisms
 TAS and bacterially contaminated platelets
 Laboratory workup for the diagnosis of TAS
 Treatment of TAS

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Febrile Non-Hemolytic Transfusion


Reaction (FNHTR)
 An acute complication of transfusion presenting
with 1°C (1.8°F) increase in body temperature
that can be accompanied by chills, nausea
and/or vomiting, tachycardia, increase in blood
pressure and tachypnea
 Asymptomatic rise in body temperature in a
hypothermic patient not considered FNHTR

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Febrile Non-Hemolytic Transfusion


Reaction (FNHTR) (cont’d)
 Etiology attributed to two different white cell
related mechanisms
 Immune-mediated mechanism
 Platelet storage changes and cytokines
released from white cells present in the
component
 Treatment and prevention of FNHTR
Copyright © 2012 F.A. Davis Company
Modern Blood Banking & Transfusion Practices
6th Edition

Allergic Transfusion Reactions (ALTR)


 Acute, immune complications of transfusion
presenting with a variety of symptoms and severity
of the reaction
 Occurs as a response of recipient antibodies to an
allergen present in the blood component
 Symptoms associated with ALTR
 Pathophysiology of ALTR
 Treatment and prevention of ALTR

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Related Acute Lung Injury


(TRALI)
 Consists of an acute transfusion reaction presenting
with respiratory distress and severe hypoxemia during
or within 6 hours of transfusion in the absence of other
recognized causes of acute lung injury
 Can be accompanied by fever and/or hypotension
 Considered the leading cause of transfusion-associated
fatalities

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Related Acute Lung Injury


(TRALI) (cont’d)
 Patients with specific clinical diagnoses (infection, surgery,
trauma) have increased risk
 Two different hypothetical pathways have been postulated
for the pathogenesis of TRALI
 Immune TRALI
 Implicated leukocyte antibodies and components
 Non-immune TRALI
 Individual predisposition of the patient

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Related Acute Lung Injury


(TRALI) (cont’d)
 Both pathways lead to a final common pathway that
causes damage to the endothelium, leading to
pulmonary capillary permeability and resulting in
non-cardiogenic pulmonary edema
 Management/treatment of TRALI
 Management of donor implicated in TRALI
 Preventive interventions

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Associated Circulatory


Overload (TACO)
 Acute non-immune complication of transfusion
presenting with respiratory distress, hypoxemia that
can be accompanied by other symptoms during or
after transfusion
 Occurs when the ability of the patient’s cardiovascular
system to handle additional workload is exceeded,
manifesting as congestive heart failure
 Symptoms associated with TACO

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion Associated Circulatory


Overload (TACO) (cont’d)
 Chest radiography findings
 Utility of brain natriuretic peptide (BNP)
assay
 Treatment of TACO, including transfusion
rate
 Patients at risk of developing TACO

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Adverse Events Associated with


Massive Transfusions
 Comorbid factors
 Patient monitoring for development of signs
and symptoms and changes in laboratory
values
 Appropriate use of medications and blood
components

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Delayed Serologic/Hemolytic
Transfusion Reaction (DSHTR)
 The detection of "new" red cell antibodies after 24
hours of transfusion
 Occurs most commonly secondarily to an amnestic
response but may also occur during a primary
immune response
 May (delayed hemolytic) or may not (delayed
serologic) be associated with shortened survival of
the transfused cells

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Delayed Serologic/Hemolytic
Transfusion Reaction (DSHTR) (cont’d)
 Often noted when a new sample is tested during
a request for a type and crossmatch and the
hemoglobin levels are lower than anticipated
 Implicated antibody specificity, thermal activity
and ability to fix complement
 Immunohematology evaluation

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion-Associated Graft Versus


Host Disease (TAGVHD)
 A delayed immune transfusion reaction due
to an immunologic attack by viable donor
lymphocytes contained in the transfused
blood component against the transfusion
recipient
 Symptoms of TAGVHD
 Laboratory test results in GVHD

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion-Associated Graft Versus


Host Disease (TAGVHD) (cont’d)
 Conditions leading to development of TAGVHD
 HLA haplotypes of donor and recipient
 Patient populations at risk for TAGVHD
 Recommended diagnostic testing
 Gamma irradiation of cellular blood
components
Copyright © 2012 F.A. Davis Company
Modern Blood Banking & Transfusion Practices
6th Edition

Post-Transfusion Purpura (PTP)


 A delayed immune complication of transfusion
presenting with profound thrombocytopenia
1–24 days post transfusion
 Mechanism of PTP
 Standard of treatment
 Considerations for subsequent transfusions

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

Iron Overload
 A delayed, non-immune complication of
transfusion, presenting with multi-organ
(liver, heart, endocrine organs) damage
secondary to excessive iron accumulation
 Chelation therapy for iron overload

Copyright © 2012 F.A. Davis Company


Modern Blood Banking & Transfusion Practices
6th Edition

“Silent” Transfusion-Related Adverse


Events
 Incidents/errors not necessarily presenting with
transfusion-associated symptoms
 Potential to cause adverse effects
 Sample collection errors
 Red blood cell alloimmunization
 Platelet alloimmunization
 Transfusion overdosing and underdosing
Copyright © 2012 F.A. Davis Company
Modern Blood Banking & Transfusion Practices
6th Edition

Transfusion-Related Adverse Events


in Special Patient Scenarios
 Special patient populations and transfusion
circumstances warranting discussion
 Infusion of plasma derivatives
 Therapeutic apheresis
 Neonatal transfusions
 Autologous blood transfusions

Copyright © 2012 F.A. Davis Company

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy